"In 2009, Marc Tessier-Lavigne, then a top executive at the biotechnology company #Genentech, was the primary author of a #scientific paper published in the prestigious journal Nature that claimed to have found the potential cause for brain degeneration in #Alzheimer’s patients.
[…] Neither a correction nor a retraction was issued, and the paper stands to this day."
Impressive investigation by #TheoBaker: https://stanforddaily.com/2023/02/17/internal-review-found-falsified-data-in-stanford-presidents-alzheimers-research-colleagues-allege/ #medicines #authorship #science #historyOfScience #ethics 🧶
#genentech #scientific #alzheimer #theobaker #medicines #authorship #science #historyofscience #ethics
My latest clinical pipeline column for @NatureMedicine is out today.
It's a look at the recent approval of mosunetuzumab, #Genentech's bispecific anti CD20/CD3 monoclonal antibody
for relapsed or refractory follicular #lymphoma.
#FollicularLymphoma #Hematology #MonoclonalAntibody #DrugDevelopment
#FollicularLymphoma #genentech #lymphoma #hematology #monoclonalantibody #drugdevelopment
Sun Pharma to purchase Concert Pharmaceuticals for $576M — Moderna CEO in talks with China to supply COVID vaccines — Roche’s Tecentriq to be filed for early-stage liver cancer -- See more on our front page news http://bit.ly/w28kSd #mergersandacquisitions #sunpharma #moderna #stephanebancel #covid #covid19 #vaccines #china #roche #genentech #livercancer #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
#mergersandacquisitions #sunpharma #moderna #stephanebancel #covid #covid19 #vaccines #China #roche #genentech #livercancer #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
#COVID NEWS (USA)
#FDA approved a new indication for the #monoclonal #antibody tocilizumab (Actemra, #Genentech) for treatment of hospitalized adults with #COVID19 receiving systemic corticosteroids and requiring supplement oxygen, mechanical ventilation (invasive or non-invasive), or #ECMO.
#COVID #FDA #monoclonal #antibody #genentech #COVID19 #ECMO